PathAI has announced a multi-year strategic collaboration with MedStar Health to deploy PathAI’s AISight Dx Digital Pathology Platform and various AI algorithm products across the multi-site network.
AISight Dx is PathAI’s cloud native digital pathology image management system designed to support laboratory workflows, clinical operations and research initiatives. It is FDA-cleared for primary diagnosis in the US and is CE‑IVD–marked for primary diagnosis in the EEA, UK, and Switzerland. It combines enterprise scale slide management, viewing, and collaboration with seamless AI integration to drive enhanced efficiency and improve speed and consistency. MedStar Health will also deploy algorithms, including ArtifactDetect and TumorDetect, to further transform pathology workflows across their network of laboratories supporting over 40 pathologists. ArtifactDetect is a workflow tool on AISight Dx. TumorDetect is for Research Use Only. Not for use in diagnostic procedures.

